In 8 years, India's BioEconomy has risen nearly tenfold to $80 Bn. In 8 years, it might reach $300 Bn. Biotechnology can potentially alter India's economy and is called 'India's Sunrise Sector'.

India has to lead the battle against COVID-19, spending over $1 billion on R&D in 2021. India has made great strides in fostering a conducive environment for biotech innovation, with over 5300 biotech companies in 2022.

The biotech juggernaut in India aims to make the country a $100 billion bio-manufacturing centre by 2025. India's bioeconomic footprint is growing via capacity building, infrastructural development, and policy formulation and change.



Current Issue

Current Issue

01-2026

Connect Us :

WhatsApp